Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Interventional × Phlebotomy × Clear all

Phase

Status

Completed 7 Withdrawn 1 Unknown 1 Terminated 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Thrombosis 1 Polycythemia Vera 1 Polycythemia 1

Interventions

Cyclophosphamide 356 Carboplatin 299 pembrolizumab 279 Cisplatin 279 Gemcitabine 278 Radiotherapy 262 Paclitaxel 260 Docetaxel 250 Bevacizumab 219 Rituximab 207 Capecitabine 197 Nivolumab 188 Dexamethasone 177 Fluorouracil 176 fludarabine 163 Oxaliplatin 156 Doxorubicin 139 Irinotecan 132 Leucovorin 131 Etoposide 129 Pemetrexed 127 Cytarabine 124 fludarabine phosphate 113 Bortezomib 113 Lenalidomide 109 Filgrastim 109 Cetuximab 106 Erlotinib Hydrochloride 105 Temozolomide 99 Radiation 96

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01645124 2012-07-20

CYTO-PV

Consorzio Mario Negri Sud

Phase 3 Terminated

Polycythemia, Polycythemia Vera, Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡